|
GSK3A expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.2165000097304E-09 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.81349998854097E-09 |
| Normal-vs-Stage2 |
1.219060E-03 |
| Normal-vs-Stage3 |
5.667500E-02 |
| Normal-vs-Stage4 |
4.310000E-01 |
| Stage1-vs-Stage2 |
6.557400E-01 |
| Stage1-vs-Stage3 |
1.199170E-01 |
| Stage1-vs-Stage4 |
4.250600E-01 |
| Stage2-vs-Stage3 |
1.611170E-01 |
| Stage2-vs-Stage4 |
2.829000E-01 |
| Stage3-vs-Stage4 |
8.992000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.66010005531581E-09 |
| Normal-vs-AfricanAmerican |
2.22400000005063E-06 |
| Normal-vs-Asian |
3.830600E-01 |
| Caucasian-vs-AfricanAmerican |
7.114000E-01 |
| Caucasian-vs-Asian |
6.605200E-01 |
| AfricanAmerican-vs-Asian |
5.726600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.79469772376706E-11 |
| Normal-vs-Female |
1.222240E-01 |
| Male-vs-Female |
6.974200E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
8.38230000000939E-05 |
| Normal-vs-Extreme_Weight |
9.4489005508791E-10 |
| Normal-vs-Obese |
3.114200E-02 |
| Normal-vs-Extreme_Obese |
1.064290E-03 |
| Normal_Weight-vs-Extreme_Weight |
3.812200E-01 |
| Normal_Weight-vs-Obese |
1.545450E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.056600E-01 |
| Extreme_Weight-vs-Obese |
1.215700E-02 |
| Extreme_Weight-vs-Extreme_Obese |
3.884400E-01 |
| Obese-vs-Extreme_Obese |
6.448000E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.435000E-01 |
| Normal-vs-Age(41-60Yrs) |
2.202900E-04 |
| Normal-vs-Age(61-80Yrs) |
1.75449654804538E-11 |
| Normal-vs-Age(81-100Yrs) |
3.387800E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.042800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.496270E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.139900E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.835900E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.932300E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.768800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
6.88430000006512E-07 |
| Normal-VS-Type2 PRCC |
1.29099952950185E-10 |
| Normal-VS-KIRP CIMP |
4.058800E-01 |
| Normal-VS-Unclassified PRCC |
7.357100E-04 |
| Type1 PRCC-VS-Type2 PRCC |
2.006000E-02 |
| Type1 PRCC-VS-KIRP CIMP |
8.475500E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
6.751000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.049020E-04 |
| Type2 PRCC-VS-Unclassified PRCC |
1.802780E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
9.362300E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.71869999957097E-07 |
| Normal-vs-N1 |
3.873400E-01 |
| Normal-vs-N2 |
7.509800E-01 |
| N0-vs-N1 |
2.186300E-02 |
| N0-vs-N2 |
3.026100E-02 |
| N1-vs-N2 |
4.724400E-01 |
|
|
